Results 51 to 60 of about 29,547 (250)
Journal of Medical Case Reports, 2023 Introduction Advances in the treatment of biliary tract cancer have been made possible through gains in genomic and epigenetic tumor understanding. The use of fibroblast growth factor receptor inhibitor has enabled significant clinical improvement in a ...
Andreas Edwin Juarso +2 more
doaj +1 more source
Ablation of Intrahepatic Cholangiocarcinoma
Seminars in Interventional Radiology, 2019 AbstractIntrahepatic cholangiocarcinoma is the second most common primary liver cancer but represents only a small portion of all primary liver cancers. At the time of diagnosis, patients are often not surgical candidates due to tumor burden of other comorbidities. In addition, there is a very high rate of tumor recurrence after resection.
Jennifer, Sweeney +3 more
openaire +3 more sources
Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma.
, 2015 Intrahepatic cholangiocarcinomas are the second most common primary liver malignancies with an increasing incidence over the past decades. Due to a lack of early symptoms and their aggressive oncobiological behavior, the diagnostic approach is ...
Bartella, Isabel, Dufour, Jean-François
core +1 more source
Annals of Gastroenterological Surgery, EarlyView.In this multicenter retrospective study conducted by the Biliary Tract Club, we compared survival outcomes between gemcitabine–cisplatin–S‐1 (GCS) and gemcitabine–cisplatin (GC) in patients with unresectable biliary tract cancer, with a particular focus on conversion surgery. GCS was associated with longer overall and progression‐free survival compared
Hisashi Kosaka +27 more
wiley +1 more source
Conventional, Functional and Radiomics Assessment for Intrahepatic Cholangiocarcinoma.
, 2022 I uploaded the images of the manuscript "Conventional, Functional and Radiomics Assessment for Intrahepatic Cholangiocarcinoma"
Vincenza Granata
core +1 more source
Annals of Gastroenterological Surgery, EarlyView.This retrospective study of 249 patients undergoing hepatectomy after right portal vein embolization (PVE) demonstrated that major recanalization–defined as recanalization more than one segment within the embolized liver–was associated with impaired regeneration of the future liver remnant (FLR).
Masao Uemura +9 more
wiley +1 more source
, 2012 OBJECTIVES To examine the outcomes of a hepatectomy for intrahepatic cholangiocarcinoma (IHC) and to clarify the prognostic impact of a lymphadenectomy and the surgical margin. Large series of patients who were surgically treated for IHC are scarce. Thus,
Capussotti, Lorenzo +41 more
core +1 more source
Recent Advances in Functional Liver Volumetry: Emphasis on 99mTc‐GSA SPECT/CT Fusion Imaging
Annals of Gastroenterological Surgery, EarlyView.Functional liver volumetry enables more accurate assessment of the future liver remnant by integrating anatomical and functional information, improving risk stratification before major hepatectomy. Among available techniques, 99mTc‐GSA SPECT/CT fusion imaging enables precise regional functional assessment and more reliable prediction of post ...
Toru Beppu +4 more
wiley +1 more source
Advanced Intelligent Discovery, EarlyView.This study introduces a tree‐based machine learning approach to accelerate USP8 inhibitor discovery. The best‐performing model identified 100 high‐confidence repurposable compounds, half already approved or in clinical trials, and uncovered novel scaffolds not previously studied. These findings offer a solid foundation for rapid experimental follow‐up,
Yik Kwong Ng +4 more
wiley +1 more source
Unclassified Diffuse Ductal Cholangiocarcinoma; Report of a Case
Case Reports in Surgery, 2014 Cholangiocarcinoma (CCA) is the second most common malignant tumor of the liver. It is simply classified as intrahepatic and extrahepatic CCA (including perihilar and distal extra hepatic CCA) according to the anatomic localization.
Ünal Aydın +6 more
doaj +1 more source